OptiNose, Inc.
OPTNDelisted May 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001494650
OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding OptiNose, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 40 | −24 |
| SharesConverted for a 1-for-15 split | 7.26M | 753.8 | 7.31M | +50.5K (+0.7%) |
| Value | $72.7M | $7.58K | $48.7M | −$24.0M (−33.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held OptiNose, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acorn Capital Advisors, LLC | 422,813 | $2.82M | 1.52% |
| New England Capital Financial Advisors LLC | 666 | $276 | 0.00% |
| SBI Securities Co., Ltd. | 39 | $261 | 0.00% |
| Danske Bank A/S | 1 | $7 | 0.00% |
Sold out (28)
Institutions that held OptiNose, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (1)
Institutions that held OptiNose, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 11,307 | $7.58K |